Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "Removal of small/middle molecular weight toxins via filtration/diffusion/convection" does **not refer to a specific molecule or receptor**, but rather describes the **physicochemical principles** underlying extracorporeal blood purification therapies such as hemodialysis and hemofiltration. These therapies aim to clear uremic toxins from the bloodstream when native renal function is impaired. This entry describes physical processes—filtration, diffusion, convection—not the action of drugs on a molecular target. Drugs do not directly interact with this "target" as it is a process; however, drugs may be removed by these processes during dialysis. Biomarkers such as urea, creatinine, beta 2-microglobulin are used to monitor efficacy of these processes but are not biomarkers for patient selection for this "target." **Small molecules** (<500 Da), such as urea and potassium, are primarily removed by **diffusion**, which relies on concentration gradients across semi-permeable membranes. **Middle molecules** (typically 500–60,000 Da), including low-molecular-weight proteins like beta 2-microglobulin and certain cytokines[5][7], are more effectively cleared by **convection**, where solvent drag moves solutes across membranes driven by pressure gradients. Filtration refers broadly to passage through semi-permeable barriers. These mechanisms do not represent druggable targets like receptors or enzymes but instead describe how artificial kidneys mimic natural nephron functions using engineered filters. The efficiency depends on membrane characteristics (pore size/selectivity), flow rates, pressure differentials, and other technical parameters[2][4][6]. Because this entry does not correspond to an individual biomolecule or receptor but rather summarizes therapeutic strategies/processes for toxin clearance in renal failure patients—and because it cannot be classified under standard molecular families—it should be flagged as an incorrect target name if strict curation rules require discrete entities. > “There are three principle ways by which any solute (= any substance dissolved in water) can be removed from solution: Diffusion; Convection; Adsorption... The major mechanisms of dialysis use all three...”[2] > “Convection is bulk-flow of solute across a semi-permeable membrane together with solvent... one of the main mechanisms of middle molecule clearance...”[4] > “Uremic toxins with a molecular weight less than 500 Da are classified as small nitrogenous waste products... Middle molecules were defined as toxins in the range 500–60 000 Da...”[5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Removal of small and middle molecular weight toxins via filtration, diffusion, and convection.